Corbie-Smith G. The continuing legacy of the Tuskegee Syphilis Study: Considerations for clinical investigation // The American Journal of the Medical Sciences. 1999. January. Vol. 317. № 1. P. 5–8.
Reverby S. M. More than fact and fiction: Cultural memory and the Tuskegee syphilis study // The Hastings Center Report. 2001. September-October. Vol. 31. № 5. P. 22–28.
Annas G. J. The changing landscape of human experimentation: Nuremberg, Helsinki and Beyond // Health Matrix: The Journal of Law-Medicine. 1992. Vol. 2. № 2. P. 119–140.
Seidelman W. E. Nuremberg lamentation: for the forgotten victims ofmedical science // BMJ. 1996. December 7. Vol. 313. № 7070. P. 1463–1467.
Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Washington, D. C.: U. S. Government Printing Office, 1949. Vol. 2. P. 181–182.
Public health // JAMA. 1896. June 6. Vol. XXVI. № 23. P. 1138–1140.
Report IV. Contemporary Issues in Medicine: Basic Science and Clinical Research. Medical School Objectives Project, 2001.
Millum J., Grady C. The ethics of placebo-controlled trials: methodological justifications // Contemporary clinical trials. 2013. November. Vol. 36. № 2. P. 510–514.
Challenging ethical issues in contemporary research on human beings. National Health and Medical Research Council (NHMRC). Canberra, ACT: Australian Government, 2007.
Hiltner S. The Tuskegee Syphilis Study under review // Christian century. 1973. November 28. Vol. 90. № 43. P. 1174–1176.
Howard-Jones N. Human experimentation in historical and ethical perspectives // Social Science & Medicine. 1982. Vol. 16. № 15. P. 1429–1448.
Bernstein J. E. Ethical considerations in human experimentation // Journal of clinical pharmacology. 1975. August- September. Vol. 15. № 8–9. P. 579–590.
Katz R. V. The legacy of the Tuskegee Syphilis Study: assessing its impact on willingness to participate in biomedical studies // Journal of health care for the poor and underserved. 2008. November. Vol. 19. № 4. P. 1168–1180.
Rasko J., Power C. Dr Con Man: the rise and fall of a celebrity scientist who fooled almost everyone // The Guardian. 2017. September 1.
The Macchiarini case: investigation of the synthetic trachea transplantations at Karolinska University Hospital. 2016. August 31.
Novella S. Selling Stem Cell Hype // Skeptical Inquirer. 2011. September/October. Vol. 35.5.
Shuster E. Fifty years later: The significance of the Nuremberg Code // The New England Journal of Medicine. 1997. November. Vol. 337. P. 1436–1440.
The Human Radiation Experiments: Final Report of the Advisory Committee on Human Radiation Experiments. Oxford University Press, 1996.
Киселев В. А. Биоэтический словарь. 2-е изд., испр. и доп. Екатеринбург: УГМА, 2006
Часть четвертая
Vineis P. History of bias // Sozial-und Präventivmedizin. 2002. September. Vol. 47. № 3. P. 156–161.
Buck C., Llopis A. et al. The challenge of epidemiology: issues and selected readings. Pan American Health Org, 1988.
Karamanou M., Panayiotakopoulos G., Tsoucalas G., Kousoulis A., Androutsos G. From miasmas to germs: a historical approach to theories of infectious disease transmission // Le Infezioni in Medicina. 2012. March. Vol. 20. № 1. P. 58–62.
Sterner C. S. Brief history of miasmic theory // Bulletin of the History of Medicine. 1948. Vol. 22.
Юркова З. В. Сенная площадь. Вчера, сегодня, завтра. М.: Центрполиграф, 2011.
Bosin Y. V. Russia, cholera riots of 1830–1831 / Ness I. ed. International Encyclopedia of Revolution and Protest. Blackwell Publishing, 2009. P. 2877–2878.
McGrew R. E. The first Russian cholera epidemic: themes and opportunities // Bulletin of the History of Medicine. 1962. January 1. Vol. 36. P. 220.
Snow J. The cholera at Albion terrace // London Medical Gazette. 1849. September. Vol. 44. P. 504–505.
Hill A. B. Snow – An Appreciation // Proceedings of the Royal Society of Medicine. 1955. Vol. 48. P. 1008–1012.
Parkes E. A. Mode of Communication of Cholera. By John Snow, MD: Second Edition – London, 1855, pp 162 // International Journal of Epidemiology. 2013. Vol. 42. № 6. P. 1543–1552.
Snow J. On the mode of communication of cholera. John Churchill, 1855.
Budd W. Malignant Cholera: its cause, mode of propagation, and prevention // International Journal of Epidemiology. 2013. Vol. 42. № 6. P. 1567–1575.
Smith G. D. Commentary: Behind the Broad Street pump: aetiology, epidemiology and prevention of cholera in mid-19th century Britain // International Journal of Epidemiology. 2002. October. Vol. 31. № 5. P. 920–932.
Ackerknecht E. H. Anticontagionism between 1821 and 1867: The Fielding H. Garrison Lecture // International Journal of Epidemiology. 2009. February. Vol. 38. № 1. P. 7–21.
Koch R. An address on cholera and its bacillus // British Medical Journal. 1884. September. Vol. 2. № 1236. P. 453–459.
Howard-Jones N. Robert Koch and the cholera vibrio: a centenary // British medical journal (Clinical research ed.). 1984. February 4. Vol. 288. № 6414. P. 379–381.
Blevins S. M., Bronze M. S. Robert Koch and the ‘golden age’ of bacteriology // International Journal of Infectious Diseases. 2010. September. Vol. 14. № 9, e744–751.
Barua D. The global epidemiology of cholera in recent years // Proceedings of the Royal Society of Medicine. 1972. May. Vol. 65. № 5. P. 423–428.
Cholera vaccines: WHO position paper // Weekly Epidemiological Record. 2010. Vol. 85. № 13. P.117–128.
Rothman K. J., Greenland S. Types of Epidemiologic Studies / Rothman K. J., Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1998. P. 67–78.
Vandenbroucke J. P., Pearce N. Case – control studies: basic concepts // International Journal of Epidemiology. 2012. Vol. 41. № 5. P. 1480–1489.
Rubin D. B. Estimating causal effects of treatments in randomized and nonrandomized studies // Journal of Educational Psychology. 1974. Vol. 66. № 5. P. 688–701.
Parascandola M. Two approaches to etiology: the debate over smoking and lung cancer in the 1950s // Endeavour. 2004. June. Vol. 28. № 2. P. 81–86.
White C. Research on smoking and lung cancer: A landmark in the history of chronic disease epidemiology // The Yale Journal of Biology and Medicine. 1990. Vol. 63. № 1. P. 29–46.
Mahmood S. S., Levy D., Vasan R. S., Wang T. J. The framingham heart study and the epidemiology of cardiovascular diseases: A historical perspective // Lancet. 2014. March 15. Vol. 383. № 9921. P. 999–1008.
Song J. W., Chung K. C. Observational studies: Cohort and case-control studies // Plastic and reconstructive surgery. 2010. December. Vol. 126. № 6. P. 2234–2242.
Ending the tobacco problem: A blueprint for the nation. Washington, DC: Institute of Medicine, 2007.
Ridge C. A., McErlean A. M., Ginsberg M. S. Epidemiology of Lung Cancer // Seminars in interventional radiology. 2013. June. Vol. 30. № 2. P. 93–98.
Talhout R., Schulz T., Florek E., Van Benthem J., Wester P., Opperhuizen A. Hazardous compounds in tobacco smoke // International journal of environmental research and public health. 2011. February. Vol. 8. № 2. P. 613–628.
Pfeifer G. P, Denissenko M. F., Olivier M., Tretyakova N., Hecht S. S., Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers // Oncogene. 2002. October. Vol. 21. P. 7435–7451.
Hecht S. S. Tobacco smoke carcinogens and lung cancer // Journal of the National Cancer Institute. 1999. July 21. Vol. 91. № 14. P. 1194–1210.
Hecht S. S. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new // Carcinogenesis. 2005. Vol. 26. № 9. P. 1488–1492.
Tobacco smoke and involuntary smoking / IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 83. International Agency for Research on Cancer, Lyon, 2004.
Glantz S. A., Bero L. A., Slade J., Barnes D. E., Hanauer P. (eds.). The Cigarette Papers. University of California Press, 1998.
Fisher R. Cigarettes, cancer, and statistics // The Centennial Review of Arts & Science. 1958. Vol. 2. P. 151–166.
Heath C. W. Differences between smokers and nonsmokers // Archives of Internal Medicine. 1958. February. Vol. 101. № 2. P. 377–388.
Morris J. N., Crawford M. D. Coronary heart disease and physical activity of work: Evidence of a national necropsy survey // British Medical Journal. 1958. December 20. Vol. 2. № 5111. P. 1485–1496.
Morris J. N., Clayton D. G., Everitt M. G., Semmence A. M., Burgess E. H. Exercise in leisure time: coronary attack and death rates // British heart journal. 1990. Vol. 63. № 3. P. 325–334.
Fedak K. M., Bernal,A., Capshaw Z. A., Gross S. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology // Emerging themes in epidemiology. 2015. Vol. 12. № 1. P. 14.
Howick J., Glasziou P., Aronson J. K. The evolution of evidence hierarchies: what can Bradford Hill’s ‘guidelines for causation’ contribute? // Journal of the Royal Society of Medicine. 2009. Vol. 102. № 5. P. 186–194.
Di Cicco M. E., Ragazzo V., Jacinto T. Mortality in relation to smoking: the British Doctors Study // Breathe (Sheffield, England). 2016. September. Vol. 12. № 3. P. 275–276.